Industry News
Algae bioreactors in pipes
Engineers at GF Piping Systems have succeeded in finding the balance between light permeability and durability. They have developed a piping system made of transparent PVC, which allows sufficient light to pass through in the right wavelength for microalgae to be grown in the interior of the pipe. [ + ]
BioDiem launches $2.5m rights issue
BioDiem (ASX:BDM) has commenced an up to $2.5m rights issue to raise funds for its various vaccine and infectious disease development programs. [ + ]
Vale Nancy Millis AC, Australia’s “first lady” of biotechnology
The Australian life sciences community is mourning the loss of Emeritus Professor Nancy Millis AC, who passed away this weekend at the age of 90. [ + ]
AusBiotech & Beacon to partner on key investment events
AusBiotech and Beacon Events, organiser of the largest resource sector investor event in the Asia Pacific Region – Mines and Money – have announced a partnership to deliver biotechnology investor meetings in Hong Kong and Sydney until 2015. [ + ]
Nanotechnology device aims to prevent malaria deaths through rapid diagnosis
A pioneering mobile device using cutting-edge nanotechnology to rapidly detect malaria infection and drug resistance could revolutionise how the disease is diagnosed and treated. [ + ]
Research powerhouses join forces for manufacturing
Monash University and CSIRO will build on their shared strengths with an agreement to develop a world-class innovation precinct that aims to underpin the future of Australian manufacturing. [ + ]
Avita gets more US army funds for ReCell trial
Avita Medical (ASX:AVH) has secured additional funding from the US Department of Defense to support the FDA trial for its ReCell Spray-On-Skin in burn injuries. [ + ]
NZP to produce drug for NIH trial
New Zealand Pharmaceuticals (NZP) has announced it will be involved in a phase I trial treating rare genetic disease Hereditary Inclusion Body Myopathy (HIBM) launched by the US National Institutes of Health (NIH). [ + ]
Kinomics research centre to develop next generation drugs
A new dual-site research centre focusing on kinomics is now open for business, focusing on developing new drugs to battle cancer and other diseases. [ + ]
CSL near diabetes breakthrough
A drug candidate developed by CSL (ASX:CSL) which blocks the protein VEGF-B prevented the development or progression of type-2 diabetes in three separate animal trials. [ + ]
Government proposes “tough new standards” for Innovation Patents
The Federal Government said in media release this week that it is “considering tough new standards for Innovation Patents in order to discourage large companies from abusing the IP system.” [ + ]
Thermo Fisher Scientific launches chemical and reagents selection handbook
Thermo Fisher Scientific has announced the launch of its new Fisher Chemical and Fisher BioReagents Laboratory Reagents Handbook, an easy-to-use reference guide for one-stop access to the company’s comprehensive laboratory reagent ranges. [ + ]
AHG’s CardioCel receives special access approval from TGA
Allied Healthcare has had a win in the step to see its congenital heart defect treatment, CardioCel, approved for use across Australia. [ + ]
Free biosciences exhibition sheds light on the meaning of life
A new University of Sydney exhibition chronicles some of Australia’s most significant advances in the biological sciences during the past half-century. ‘The Meaning of Life: Celebrating 50 years of Biological Sciences’ marks the anniversary of the schools of Zoology and Botany’s amalgamation into the School of Biological Sciences in 1963. [ + ]
AusBiotech urges Business Tax Working Group to leave R&D Tax Incentive intact
AusBiotech has made a submission to Treasury’s Business Tax Working Group (BTWG) in response to its recent discussion paper suggesting that the 40% offset of the newly implemented R&D Tax Incentive be targeted for removal or reduction. [ + ]